Sandoz is offering treprostinil injection for subcutaneous administration to treat patients diagnosed with pulmonary arterial hypertension. Sandoz treprostinil injection was the first generic of ...
Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors. The Food and Drug Administration (FDA) approval of ...
This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...
Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...
New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...
Dublin, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The "Injection Devices for Subcutaneous Self-Administration" report has been added to ResearchAndMarkets.com's offering. Because of the ongoing need for ...
The gastric hormone ghrelin appears a useful agent to stimulate food intake in people with anorexia of illness. The loss of ghrelin's acyl group renders it inactive, thus it has been thought that ...
MARTINSRIED, GERMANY and MUNICH, GERMANY--(Marketwire - Nov 12, 2012) - MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that subcutaneous administration of its HuCAL-based ...
Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma For the clinical development of ...
To determine the efficacy of a long-acting oxyntomodulin (OXM) analogue, OXM6421, in inhibiting food intake and decreasing body weight in lean and diet-induced obese (DIO) rodents. The glucagon-like ...
DUBLIN--(BUSINESS WIRE)--The "Injection Devices for Subcutaneous Self-Administration" report has been added to ResearchAndMarkets.com's offering. Because of the ongoing need for repeat dosing posed by ...
Dublin, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The "Injection Devices for Subcutaneous Self-Administration" report has been added to ResearchAndMarkets.com's offering. Because of the ongoing need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback